- 专利标题： CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE
-
申请号： EP20177579.8申请日： 2015-10-21
-
公开(公告)号： EP3760618A1公开(公告)日： 2021-01-06
- 发明人: ROZAMUS, Leonard, W. , SHARMA, Pradeep
- 申请人： ARIAD Pharmaceuticals, Inc.
- 申请人地址： US Cambridge, MA 02139 26 Landsdowne Street
- 代理机构： Oates, Edward Christopher
- 优先权： US201462066849 P 20141021
- 主分类号： C07D239/48
- IPC分类号： C07D239/48 ; A61K31/506 ; A61P35/00
摘要：
Novel crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.
信息查询
